Our Pricing

UK's Cheapest Weight Loss Injection - Cured Pharmacy

Published on: June 03, 2026

Finding the cheapest weight loss injection UK pharmacy with transparent pricing can be challenging. At Cured Pharmacy, we offer genuine UK-licensed weight loss injections including Mounjaro, Wegovy, and Saxenda with upfront pricing from £135.00 free clinical consultation by UK prescribers, and 100% discreet delivery to your door.

How GLP-1 Weight Loss Injections Work

GLP-1 receptor agonists represent the most significant advancement in weight management treatment licensed by the MHRA in recent years. These medications mimic naturally occurring hormones that regulate appetite, slow gastric emptying, and enhance insulin secretion when blood glucose levels rise [1].

Tirzepatide (Mounjaro) works through a dual mechanism, activating both GIP and GLP-1 receptors simultaneously. This dual action produces superior weight reduction outcomes compared to single-pathway treatments. In the SURPASS-3 trial, participants achieved an average 22.5% body weight reduction over 72 weeks on the highest maintenance dose [1].

Semaglutide-based treatments like Wegovy target GLP-1 receptors exclusively. The STEP-1 trial demonstrated an average 14.9% body weight reduction over 68 weeks in participants receiving 2.4mg weekly semaglutide injections [2]. Liraglutide (Saxenda), administered daily rather than weekly, showed an average 8% body weight reduction in the SCALE trial over 56 weeks [3].

All prescription weight loss injections available at Cured Pharmacy require clinical assessment by a UK-registered prescriber to ensure medical suitability and appropriate dosing.

Comparing Weight Loss Injection Costs UK

The cost of weight loss injections varies significantly across UK pharmacies, making price transparency essential for informed decision-making. At Cured Pharmacy, we believe patients deserve to see exact pricing before committing to a clinical consultation.

Pricing differences often reflect the specific medication, dose strength, and treatment duration. Weekly injections like Mounjaro and Wegovy offer greater convenience than daily alternatives, though individual response and tolerability ultimately determine the most suitable option for each patient.

Transparent Pricing at Cured Pharmacy

Unlike many online pharmacies that hide costs until after consultation, we display upfront pricing before you begin your clinical assessment. Mounjaro (tirzepatide) starts from £135.00 for UK patients, representing competitive pricing for this dual-action treatment. Your final cost depends on the prescribed dose determined by your UK prescriber during the free online consultation.

We guarantee the lowest prices in the UK market for genuine, MHRA-licensed weight loss injections. Every medication is sourced from UK-licensed wholesalers and dispensed by our GPhC-registered pharmacy (9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

Mounjaro: The Most Effective Weight Loss Injection UK

Mounjaro (tirzepatide) received MHRA approval for chronic weight management in adults with a body mass index of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity. The medication comes in pre-filled KwikPen devices for once-weekly subcutaneous injection.

Dosing begins at 2.5mg weekly for four weeks, then escalates gradually to minimise gastrointestinal side effects. Maintenance doses range from 5mg to 15mg weekly, determined by individual response and tolerability. Your UK prescriber will establish the appropriate titration schedule during your clinical assessment.

Clinical Evidence for Tirzepatide

The SURPASS clinical trial programme established tirzepatide as the most effective weight loss medication currently licensed in the UK. SURPASS-2 directly compared tirzepatide against semaglutide 1mg, demonstrating superior weight reduction across all tirzepatide dose levels [4].

Participants receiving 15mg tirzepatide weekly achieved average weight loss of 12.4kg compared to 6.2kg with semaglutide 1mg over 40 weeks—nearly double the reduction [4]. These results positioned Mounjaro as the preferred option for patients requiring maximum efficacy, subject to prescriber assessment and medical suitability.

Wegovy and Saxenda: Alternative Injection Options

Wegovy (semaglutide 2.4mg) offers proven efficacy for patients who may not require the dual-action mechanism of tirzepatide. The STEP trial programme demonstrated consistent weight reduction across diverse patient populations, with 86.4% of participants achieving at least 5% body weight loss [2].

Saxenda (liraglutide) represents the daily injection option for weight management. Whilst requiring more frequent administration than weekly alternatives, some patients prefer the flexibility of daily dosing adjustments. The medication has been available in the UK since 2015, providing extensive real-world safety data.

Both medications work by activating GLP-1 receptors to reduce appetite and food intake. Common side effects include nausea, diarrhoea, and constipation, typically diminishing as treatment continues. Your prescriber will discuss expected side effects and monitoring requirements during your consultation.

Selection between these treatments depends on individual medical history, previous medication responses, lifestyle preferences, and cost considerations. Our UK clinical team assesses each patient individually to recommend the most appropriate option, subject to medical suitability.

Oral Weight Loss Treatments: Orlistat and Alternatives

For patients preferring oral medication over injections, Cured Pharmacy offers prescription-strength Orlistat 120mg and Xenical (branded orlistat), alongside lower-dose options like Orlos 60mg and Alli 60mg available without prescription.

Orlistat suits patients who prefer avoiding injections and are committed to dietary fat restriction. Weight reduction is typically more modest than with GLP-1 treatments, but the oral route and established safety profile make it appropriate for specific patient groups. Your prescriber will assess whether orlistat or injectable alternatives better match your weight management goals.

How Orlistat Differs from GLP-1 Injections

Orlistat works through an entirely different mechanism than injectable GLP-1 treatments. Rather than affecting appetite hormones, orlistat inhibits pancreatic lipase enzymes, preventing approximately 30% of dietary fat absorption [5].

This mechanism requires strict adherence to a reduced-calorie, lower-fat diet to minimise gastrointestinal side effects. Patients consuming high-fat meals whilst taking orlistat commonly experience oily stools, flatulence, and faecal urgency. Clinical trials showed average weight loss of 2.9kg more than placebo over 12 months when combined with lifestyle modification [5].

Starting Your Weight Loss Treatment Journey

Beginning treatment with weight loss injections requires realistic expectations and commitment to lifestyle modification. These medications work most effectively when combined with reduced calorie intake and increased physical activity. NICE guidelines recommend prescription weight loss medications only as part of a comprehensive weight management programme [6].

Your prescriber may recommend regular follow-up assessments to monitor progress, adjust dosing, and manage any side effects. Most patients tolerate GLP-1 treatments well, though gastrointestinal symptoms are common during initial weeks. Staying well-hydrated and eating smaller, more frequent meals can help minimise discomfort during dose escalation.

At Cured Pharmacy, we're committed to supporting your weight management journey with transparent pricing, genuine UK-licensed medications, and expert clinical guidance from our registered healthcare team. Start your free consultation today to discover which treatment option may be right for you.

The Cured Pharmacy Clinical Assessment Process

Our free online consultation takes under three minutes to complete. You'll answer questions about your medical history, current medications, weight management goals, and any previous weight loss treatments. A UK-registered prescriber reviews every assessment individually—we never use automated approvals.

If a prescription weight loss injection is deemed medically appropriate, your prescriber will determine the suitable medication and starting dose. Your treatment is then dispensed by our GPhC-registered pharmacy and dispatched in 100% discreet packaging with next-day delivery options available across the UK.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
4. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
5. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
6. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE guideline. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment and lifestyle modification.